Literature DB >> 31632785

Optimal lung cancer screening intervals following a negative low-dose computed tomography result.

Monica E Reyes1, Matthew B Schabath1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31632785      PMCID： PMC6783784          DOI： 10.21037/jtd.2019.08.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.

Authors:  Hilary A Robbins; Christine D Berg; Li C Cheung; Anil K Chaturvedi; Hormuzd A Katki
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

3.  Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study.

Authors:  Ying Liu; Hua Wang; Qian Li; Melissa J McGettigan; Yoganand Balagurunathan; Alberto L Garcia; Zachary J Thompson; John J Heine; Zhaoxiang Ye; Robert J Gillies; Matthew B Schabath
Journal:  Radiology       Date:  2017-08-24       Impact factor: 11.105

4.  Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Authors:  Nikolaus Becker; Erna Motsch; Anke Trotter; Claus P Heussel; Hendrik Dienemann; Philipp A Schnabel; Hans-Ulrich Kauczor; Sandra González Maldonado; Anthony B Miller; Rudolf Kaaks; Stefan Delorme
Journal:  Int J Cancer       Date:  2019-06-20       Impact factor: 7.396

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

7.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

8.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316

9.  Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.

Authors:  Matthew B Schabath; Pierre P Massion; Zachary J Thompson; Steven A Eschrich; Yoganand Balagurunathan; Dmitry Goldof; Denise R Aberle; Robert J Gillies
Journal:  PLoS One       Date:  2016-08-10       Impact factor: 3.240

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105
View more
  2 in total

1.  CT-guided percutaneous implantation of 125I particles in treatment of early lung cancer.

Authors:  Dong-Yong Yang; Yan-Ping Lin; Cheng Xue; Ji-Min Fan; Yi Wang; Chi Cai; Duan-Hong Song; Yi-Ming Zeng
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Radiological manifestations, histological features and surgical outcomes of pulmonary meningothelial proliferation: a case series and rethinking.

Authors:  Dong Lin; Yangli Yu; Hao Wang; Yong Fang; Jun Yin; Yaxing Shen; Lijie Tan
Journal:  Transl Lung Cancer Res       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.